Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
VHFPlus icon

12 by Georg Thieme Verlag KG


Oct 9, 2022

About VHFPlus

Interactively learn more about the therapy of non-valvular atrial fibrillation ..

The VHFPlus app offers doctors information on the treatment of atrial fibrillation (AF) with new oral anticoagulants (NOACs).

Users receive a basic introduction to the subject of AF, in which, among other things, pathogenesis, diagnostics and therapy with NOACs as well as information on rhythm and frequency control are discussed. However, you can also use fictitious case studies to expand your knowledge interactively. The following practice-relevant situations are presented in the case studies: the change of anticoagulation during the SARS-CoV-2 pandemic, the treatment of multimorbid AF patients, the treatment of aging AF patients and the treatment of patients with NOACs in the peri- and postoperative setting. A learning success control is carried out while working on the case studies by means of multiple-choice questions. Due to legal regulations (Heilmittelwerbegesetz), the app can only be used by members of the specialist group and is password-protected via DocCheck.

What's New in the Latest Version 12

Last updated on Oct 9, 2022

Fix für Android 12

Translation Loading...

Additional APP Information

Latest Version

Request VHFPlus Update 12

Uploaded by

Manuel Manzano Panganiban

Requires Android

Android 5.0+

Show More

VHFPlus Screenshots

Comment Loading...
Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.